Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and
can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) …

Acute kidney injury (AKI) is now recognized as a heterogeneous syndrome that not only
affects acute morbidity and mortality, but also a patient's long-term prognosis. In this …

Background The clinical presentation and outcomes of non-alcoholic fatty liver disease
(NAFLD)-related hepatocellular carcinoma are unclear when compared with hepatocellular …

Background Delaying renal replacement therapy (RRT) for some time in critically ill patients
with severe acute kidney injury and no severe complication is safe and allows optimisation …

Background & Aims Fibrosis is a key determinant of clinical outcomes in nonalcoholic fatty
liver disease (NAFLD), but time-dependent risk of mortality has not been reported in …

The term acute-on-chronic liver failure (ACLF) defines an abrupt and life-threatening
worsening of clinical conditions in patients with cirrhosis or chronic liver disease. In recent …

Extracorporeal Kidney-Replacement Therapy for AKI Acute kidney injury can be
accompanied by life-threatening electrolyte and metabolic abnormalities. Kidney …

In December 2019, a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was discovered in Wuhan, China, the rapid spread of which culminated in a global …

We aimed to identify prevalence and association of comorbid chronic kidney disease (CKD),
acute kidney injury (AKI) and utilization prevalence of continuous renal replacement therapy …

Importance Conventional meta-analyses with aggregated study-level data have yielded
conflicting results for the comparative effectiveness of tenofovir disoproxil fumarate vs …